The Genetic Health Information Network Summit convened for the 4th time October 25-27, 2021, in Nashville, TN. Once again, the event gathered a multi-stakeholder group of influential leaders for a solution-oriented discussion on enabling precision medicine at scale. Participants included health plans, hospital systems, clinicians, researchers, policy makers, laboratories, pharma, technology leaders, patients, and advocacy organizations.
Uniquely this year, the group took stock of the enormous impact of the COVID-19 pandemic on science, technology, policy, consumer expectations, and the healthcare system as a whole. In addition, sessions dug deep into precision oncology, data and learning systems, and evidence development in the genetic testing space.
In particular, three impactful themes emerged that differentiated the discussion from previous meetings.
- The COVID-19 pandemic sent clinical diagnostics and digital health infrastructure trends into overdrive.
- Evidence development is undergoing a radical and irrevocable change in response to a growing appetite for rapid, targeted, distributed clinical trials and real world evidence.
- Democratization of healthcare through access to technology is accelerating.
Each of these is unpacked in the paper.
Call for Case Studies
The paper also proposes a dynamic addition for the 2022 Summit (Sept 14-16, Nashville, TN). Organizers invite stakeholders from across the ecosystem to present multi-stakeholder solutions. The intent is to showcase innovations fostered by Summit participants that are enabling precision medicine at scale, providing visibility to influential leaders across the ecosystem including potential advisors, customers, partners, and sources of funding.
To learn more, complete the form on this page.